Why the study?
Is increased VE/VCO2 slope associated with increased mortality in patients with HFpEF and pulmonary hypertension?
Is increased VE/VCO2 slope associated with increased mortality in patients with HFpEF and pulmonary hypertension?
Increased VE/VCO2 slope is an independent predictor of mortality and correlates with disease severity and higher pulmonary vascular resistance in patients with HFpEF and pulmonary hypertension.
No takes yet. Share an insight, caveat, or question.
VE/VCO2 slope may aid mortality risk stratification in HFpEF-PH; leaves open prospective validation before guiding therapy.
Klaassen et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: